Showing 1 - 20 results of 54 for search 'Wu-Chou Su', query time: 0.05s Refine Results
  1. 1
    Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer

    Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer by Szu‐Chun Yang, Huang‐Tz Ou, Wu‐Chou Su, Shi‐Yi Wang

    Published 2023-04-01
    Get full text
    Article
  2. 2
    Nephrotic Syndrome Associated with Thymoma

    Nephrotic Syndrome Associated with Thymoma by Sheng-Yen Hsiao, Kwang-Yu Chang, Jang-Yang Chang, Wu-Chou Su

    Published 2014-12-01
    Get full text
    Article
  3. 3
    Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends

    Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends by Chun-Yan Shih, Pei-Ting Wang, Wu-Chou Su, Hsisheng Teng, Wei-Lun Huang

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

    Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma by Szu-Chun Yang, Chien-Chung Lin, Yi-Lin Chen, Yi-Lin Chen, Wu-Chou Su

    Published 2022-05-01
    Get full text
    Article
  5. 5
    Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan.

    Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan. by Szu-Chun Yang, Wu-Wei Lai, Jason C Hsu, Wu-Chou Su, Jung-Der Wang

    Published 2020-01-01
    Get full text
    Article
  6. 6
    First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

    First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer by Po‐Lan Su, Chian‐Wei Chen, Yi‐Lin Wu, Chien‐Chung Lin, Wu‐Chou Su

    Published 2021-02-01
    Get full text
    Article
  7. 7
    Primary Bone Marrow Large B-cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis

    Primary Bone Marrow Large B-cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis by Sin-Syue Li, Ya-Ping Chen, Kung-Chao Chang, Wu-Chou Su, Tsai-Yun Chen

    Published 2014-09-01
    Get full text
    Article
  8. 8
    A rare case of an endobronchial mass due to Neurospora intermedia

    A rare case of an endobronchial mass due to Neurospora intermedia by Wan-Lin Wu, Jen-Chieh Lee, Wu-Chou Su, Sheng-Yuan Wang, Chi-Jung Wu

    Published 2024-09-01
    Get full text
    Article
  9. 9
    Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models

    Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models by Wei‐Pang Chung, Wei‐Lun Huang, Wei‐An Liao, Wan‐Ling Huang, You‐Yu Liu, Wu‐Chou Su

    Published 2021-04-01
    Get full text
    Article
  10. 10
    Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

    Immune Checkpoint Inhibitor-Induced Myasthenia Gravis by Yi-Te Huang, Ya-Ping Chen, Wen-Chih Lin, Wu-Chou Su, Yuan-Ting Sun, Yuan-Ting Sun

    Published 2020-07-01
    Get full text
    Article
  11. 11
    Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors

    Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors by Hui-Jen Tsai, Her-Shyong Shiah, Jang-Yang Chang, Wu-Chou Su, Nai-Jung Chiang, Li-Tzong Chen

    Published 2021-03-01
    Get full text
    Article
  12. 12
    Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.

    Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinom... by Hsuan-Heng Yeh, Wen-Tsan Chang, Kuang-Chu Lu, Wu-Wei Lai, Hsiao-Sheng Liu, Wu-Chou Su

    Published 2013-01-01
    Get full text
    Article
  13. 13
    Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer

    Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer by Wan-Ting Kuo, I-Ying Kuo, Hung-Chia Hsieh, Ssu-Ting Wu, Wu-Chou Su, Yi-Ching Wang

    Published 2024-02-01
    Get full text
    Article
  14. 14
    The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.

    The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis. by Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su

    Published 2018-01-01
    Get full text
    Article
  15. 15
    FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer

    FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer by Wei-Pang Chung, Wei-Lun Huang, Wei-An Liao, Chun-Hua Hung, Chi-Wu Chiang, Chun Hei Antonio Cheung, Wu-Chou Su

    Published 2022-01-01
    Get full text
    Article
  16. 16
    Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer

    Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer by Szu-Chun Yang, Chien-Chung Lin, Wu-Wei Lai, Sheng-Mao Chang, Jing-Shiang Hwang, Wu-Chou Su, Jung-Der Wang

    Published 2018-02-01
    Get full text
    Article
  17. 17
    Oncogenic Ras-Induced Morphologic Change Is through MEK/ERK Signaling Pathway to Downregulate Stat3 at a Posttranslational Level in NIH3T3 Cells

    Oncogenic Ras-Induced Morphologic Change Is through MEK/ERK Signaling Pathway to Downregulate Stat3 at a Posttranslational Level in NIH3T3 Cells by Hsuan-Heng Yeh, Chin-Han Wu, Raghavaraju Giri, Ken Kato, Kimitoshi Kohno, Hiroto Izumi, Cheng-Yang Chou, Wu-Chou Su, Hsiao-Sheng Liu

    Published 2008-01-01
    Get full text
    Article
  18. 18
    Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

    Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis by Chung-Ying Lin, Jing-Shiang Hwang, Wen-Chung Wang, Wu-Wei Lai, Wu-Chou Su, Tzu-Yi Wu, Grace Yao, Jung-Der Wang

    Published 2019-01-01
    Get full text
    Article
  19. 19
    Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio

    Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio by Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su

    Published 2022-11-01
    Get full text
    Article
  20. 20
    IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer

    IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer by You-En Yang, Meng-Hsuan Hu, Yen-Chen Zeng, Yau-Lin Tseng, Ying-Yuan Chen, Wu-Chou Su, Chih-Peng Chang, Yi-Ching Wang

    Published 2024-05-01
    Get full text
    Article

Search Tools: